🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Evaluate mFOLFOX6 (5-Fluorouracil, Leucovorin and Oxaliplatin) chemotherapy...
Status
Active Not Recruiting
Location
University of Rochester
Start Date
2017-06-19
Trial ID
NCT03110926
Treatments Being Tested
This prospective study was designed to assess the outcomes (survival and fa...
Status
Unknown
Location
The Oregon Clinic
Start Date
2000-07
Trial ID
NCT00139633
Treatments Being Tested
The purpose of this study is to explore the activity of ZD1839 added to con...
Status
Completed
Location
The University of Chicago Medical Center
Start Date
2003-01-27
Trial ID
NCT01185171
Treatments Being Tested
This phase III trial compares pembrolizumab with radiation therapy to pembr...
Status
Active Not Recruiting
Location
Moffitt Cancer Center-International Plaza
Start Date
2023-06-08
Trial ID
NCT05721755
In this research study, is studying how Liposomal Irinotecan in combination...
Status
Recruiting
Location
Massachusetts General Hospital
Start Date
2021-06-29
Trial ID
NCT04656041
Treatments Being Tested
The purpose of this study is to determine the highest dose of a ABI-007 tha...
Status
Completed
Location
Princess Margaret Hospital
Start Date
2008-07
Trial ID
NCT00731380
Treatments Being Tested
This randomized pilot phase II trial studies how well molecular phenotyping...
Status
Terminated
Location
Case Comprehensive Cancer Center
Start Date
2015-02
Trial ID
NCT02392377
The purpose of this Phase I study is to determine the recommended phase 2 d...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2020-11-23
Trial ID
NCT04615013
Due to the increase of tumor control rate and survival rate in era of IMRT,...
Status
Unknown
Location
Multiple Locations
Start Date
2018-06-12
Trial ID
NCT03529279
Treatments Being Tested
The best treatment for resectable esophageal or gastroesophageal adenocarci...
Status
Completed
Location
Health Sciences Centre / CancerCare Manitoba
Start Date
2015-09
Trial ID
NCT01404156